PLoS ONE (Jan 2013)

Demyelination in mild cognitive impairment suggests progression path to Alzheimer's disease.

  • Cristian Carmeli,
  • Alessia Donati,
  • Valérie Antille,
  • Dragana Viceic,
  • Joseph Ghika,
  • Armin von Gunten,
  • Stephanie Clarke,
  • Reto Meuli,
  • Richard S Frackowiak,
  • Maria G Knyazeva

DOI
https://doi.org/10.1371/journal.pone.0072759
Journal volume & issue
Vol. 8, no. 8
p. e72759

Abstract

Read online

The preclinical Alzheimer's disease (AD) - amnestic mild cognitive impairment (MCI) - is manifested by phenotypes classified into exclusively memory (single-domain) MCI (sMCI) and multiple-domain MCI (mMCI). We suggest that typical MCI-to-AD progression occurs through the sMCI-to-mMCI sequence as a result of the extension of initial pathological processes. To support this hypothesis, we assess myelin content with a Magnetization Transfer Ratio (MTR) in 21 sMCI and 21 mMCI patients and in 42 age-, sex-, and education-matched controls. A conjunction analysis revealed MTR reduction shared by sMCI and mMCI groups in the medial temporal lobe and posterior structures including white matter (WM: splenium, posterior corona radiata) and gray matter (GM: hippocampus; parahippocampal and lingual gyri). A disjunction analysis showed the spread of demyelination to prefrontal WM and insula GM in executive mMCI. Our findings suggest that demyelination starts in the structures affected by neurofibrillary pathology; its presence correlates with the clinical picture and indicates the method of MCI-to-AD progression. In vivo staging of preclinical AD can be developed in terms of WM/GM demyelination.